Purchase Order SPE2DP25P0397
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company based in Lake Zurich, Illinois. The contract, valued at $2,937.60, is for the supply of Blood Pack with Anticoagulant (BLOOD PACK WITH ANT). This is a firm fixed-price purchase order contract without any set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007. The company has a...
- Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...
- This is a $1,101.28 firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products based in Lake Zurich, Illinois. The contract is for the delivery of "BLOOD PACK WITH ANT" and has an ultimate completion date of January 30, 2025. Fenwal, Inc. is a global blood technology company and a key supplier to various federal agencies, providing critical medical supplies and equipment that support...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This federal contract award is for the purchase of blood collection supplies and equipment from Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, valued at $5,743.25, was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc. on March 21, 2025, with a performance period ending on March 26, 2025. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Fenwal, Inc. is a foreign-owned, for-profit...
- This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...
- This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of anticoagulant citrate, a specialized medical product used in blood collection, separation, storage, and transfusion. The contract has a ceiling value of $1,431.36 and an ultimate completion date of November 25, 2019. Fenwal, Inc. is a registered vendor with...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract, valued at $41,848.64, is for the delivery of blood packs with anticoagulants to support the agency's medical supply chain operations. Fenwal, Inc. is a registered federal vendor that has consistently secured contracts from various agencies, including the DLA, National Institutes of Health (NIH) Clinical Center, Defense Health Agency, and Department of Veterans Affairs, to provide specialized medical equipment and consumables for healthcare and biomedical research initiatives. This contract does not have a set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
BLOOD PACK WITH ANT | SPE2DP25T2411 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 5/20/25, 1:06 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.8k | 5/20/25 |